Purpose: To determine whether the use of different bipolar resources is associated with different results on tissue and perioperative parameters in patients undergoing bipolar transurethral bladder tumor resection (bTURBT). Methods: In this single-center prospective study, patients diagnosed with bladder tumor randomized to undergo TURBT either with a Gyrus PlasmaKinetic system (n = 62) or Olympus TUR in saline (TURis) system (n = 51). Primary endpoint was to evaluate the alteration of patients’ perioperative parameters, while secondary aim was to assess the thermal effect of these 2 different bipolar devices on the resected tissue samples by a grading system determined by tissue characteristics. Results: One hundred thirteen patients were randomized in the study, and 43 were excluded from the analysis due to the exclusion criteria. There were no significant differences between the groups in terms of mean age, tumor site, number of tumors, operative time, alteration in hemoglobin or hematocrit, blood transfusion rate, catheterization time, and postoperative stay. On the other hand, the ratio of obturator jerk was significantly higher in the Olympus TURis group (p = 0.028). The histopathological analyses of both groups determined muscularis propria and cautery artifact presence without a statistically significant difference (χ2: 0.476, p = 0.788). Conclusion: Although the perioperative complications of bTURBT are low in nature, bladder perforation resulted from obturator jerk still poses a risk for extravesical tumor implantation. Urologists should be aware of this risk especially when they are using a TURis system.

1.
Bray
F
,
Ferlay
J
,
Soerjomataram
I
,
Siegel
RL
,
Torre
LA
,
Jemal
A
.
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
.
CA Cancer J Clin
.
2018
;
68
(
6
):
394
424
. .
2.
Pu
XY
,
Wang
HP
,
Wu
YL
,
Wang
XH
.
Use of bipolar energy for transurethral resection of superficial bladder tumors: long-term results
.
J Endourol
.
2008
;
22
(
3
):
545
9
. .
3.
Zhao
C
,
Tang
K
,
Yang
H
,
Xia
D
,
Chen
Z
.
Bipolar versus monopolar transurethral resection of nonmuscle-invasive bladder cancer: a meta-analysis
.
J Endourol
.
2016
;
30
(
1
):
5
12
. .
4.
Rassweiler
J
,
Schulze
M
,
Stock
C
,
Teber
D
,
De La Rosette
J
.
Bipolar transurethral resection of the prostate: technical modifications and early clinical experience
.
Minim Invasive Ther Allied Technol
.
2007
;
16
(
1
):
11
21
. .
5.
Ho
H
,
Yip
SK
,
Cheng
CW
,
Foo
KT
.
Bipolar transurethral resection of prostate in saline: preliminary report on clinical efficacy and safety at 1 year
.
J Endourol
.
2006
;
20
(
4
):
244
7
;
discussion 246–7
. .
6.
Bolat
D
,
Gunlusoy
B
,
Degirmenci
T
,
Ceylan
Y
,
Polat
S
,
Aydin
E
, et al.
Comparing the short-term outcomes and complications of monopolar and bipolar transurethral resection of non-muscle invasive bladder cancers: a prospective, randomized, controlled study
.
Arch Esp Urol
.
2016
;
69
(
5
):
225
33
.
7.
Sugihara
T
,
Yasunaga
H
,
Horiguchi
H
,
Matsui
H
,
Nishimatsu
H
,
Nakagawa
T
, et al.
Comparison of perioperative outcomes including severe bladder injury between monopolar and bipolar transurethral resection of bladder tumors: a population based comparison
.
J Urol
.
2014
;
192
(
5
):
1355
9
. .
8.
Xishuang
S
,
Deyong
Y
,
Xiangyu
C
,
Tao
J
,
Quanlin
L
,
Hongwei
G
, et al.
Comparing the safety and efficiency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer
.
J Endourol
.
2010
;
24
(
1
):
69
73
. .
9.
Anagnostopoulou
S
,
Kostopanagiotou
G
,
Paraskeuopoulos
T
,
Chantzi
C
,
Lolis
E
,
Saranteas
T
.
Anatomic variations of the obturator nerve in the inguinal region: implications in conventional and ultrasound regional anesthesia techniques
.
Reg Anesth Pain Med
.
2009
;
34
(
1
):
33
9
. .
10.
Panagoda
PI
,
Vasdev
N
,
Gowrie-Mohan
S
.
Avoiding the obturator Jerk during TURBT
.
Curr Urol
.
2018
;
12
(
1
):
1
5
. .
11.
Botto
H
,
Lebret
T
,
Barré
P
,
Orsoni
JL
,
Hervé
JM
,
Lugagne
PM
.
Electrovaporization of the prostate with the Gyrus device
.
J Endourol
.
2001
;
15
(
3
):
313
6
. .
12.
Miki
M
,
Shiozawa
H
,
Matsumoto
T
,
Aizawa
T
.
[Transurethral resection in saline (TURis): a newly developed TUR system preventing obturator nerve reflex]
.
Nippon Hinyokika Gakkai Zasshi
.
2003
;
94
(
7
):
671
7
. .
13.
Traxer
O
,
Pasqui
F
,
Gattegno
B
,
Pearle
MS
.
Technique and complications of transurethral surgery for bladder tumours
.
BJU Int
.
2004
;
94
(
4
):
492
6
. .
14.
Chakravarti
A
,
Day
DW
,
MacDermott
S
.
Extravesical transitional cell carcinoma as a result of implantation after perforation of the bladder
.
BJU Int
.
2000
;
85
(
9
):
1150
1
. .
15.
Bus
MT
,
Cordeiro
ER
,
Anastasiadis
A
,
Klioueva
NM
,
de la Rosette
JJ
,
de Reijke
TM
.
Urothelial carcinoma in both adnexa following perforation during transurethral resection of a non-muscle-invasive bladder tumor: a case report and literature review
.
Expert Rev Anticancer Ther
.
2012
;
12
(
12
):
1529
36
. .
16.
Cusano
A
,
Murphy
G
,
Haddock
P
,
Wagner
J
.
Tumour seeding as a result of intraperitoneal perforation during transurethral resection of non-muscle invasive bladder cancer
.
BMJ Case Rep
.
2014
;
2014
:
bcr2014206631
. .
17.
Kim
JH
,
Yang
WJ
.
Delayed spontaneous perforation of urinary bladder with intraperitoneal seeding following radical transurethral resection of invasive urothelial cancer: a case report
.
BMC Res Notes
.
2014
;
7
:
167
. .
18.
Skolarikos
A
,
Chrisofos
M
,
Ferakis
N
,
Papatsoris
A
,
Dellis
A
,
Deliveliotis
C
.
Does the management of bladder perforation during transurethral resection of superficial bladder tumors predispose to extravesical tumor recurrence?
J Urol
.
2005
;
173
(
6
):
1908
11
. .
19.
Mydlo
JH
,
Weinstein
R
,
Shah
S
,
Solliday
M
,
Macchia
RJ
.
Long-term consequences from bladder perforation and/or violation in the presence of transitional cell carcinoma: results of a small series and a review of the literature
.
J Urol
.
1999
;
161
(
4
):
1128
32
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.